secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-08-15T23:59:59+00:00
Accession:  0001104659-25-079322
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics announces 1-for-3 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split at ratio 1-for-3 effective 12:01 a.m. ET on August 18, 2025.
- Outstanding shares reduce from ~4.77 million to ~1.59 million; no fractional shares issued.
- Split intended to raise bid price above $1.00 to satisfy Nasdaq Listing Rule 5550(a)(2).
- Trading symbol remains ENTO; new CUSIP is 33749P507.
- Interim CEO Richard Paolone states split is necessary to maintain Nasdaq listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925079322/0001104659-25-079322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925079322/tm2523661d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-079322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer